Biosimilar Uptake in Europe: Big Challenges; Bigger Rewards

16 January 2020

Since the first treatment was approved in 2006, Europe has […]

AMR life science industry 2020 report: Successes and setbacks in fighting superbugs

16 January 2020

Hanan Sboul takes over the position of IGBA Chair

7 January 2020

Better access to medicines in Bulgaria prioritised by Medicines for Europe President

16 December 2019

Christoph Stoller, the President of Medicines for Europe, led an […]

Key topics: medicines shortages

9 December 2019

Medicines shortages: root causes and potential solutions

6 December 2019

Generic & biosimilar medicines pivotal for safe, effective and affordable access to medicines in Europe

28 November 2019

The European Commission has identified the use of generic and […]

Open letter from Medicines for Europe Executive on medicines shortages

26 November 2019

European industries unite to call for an ambitious EU industrial strategy

26 November 2019

Biosimilars ‒ Policy failings that deny savings to countries that need it most

21 November 2019